Facebook CRISPR-Cas Gene Editing Therapeutics: How Base Editing, Prime Editing, and Next-Generation Delivery Systems Are Addressing the Safety and Tissue-Specific Targeting Challenges Limiting Clinical Translation
Logo

CRISPR-Cas Gene Editing Therapeutics: How Base Editing, Prime Editing, and Next-Generation Delivery Systems Are Addressing the Safety and Tissue-Specific Targeting Challenges Limiting Clinical Transla...

クレジット
Avatar
インタビューワー
CRISPR-Cas Gene Editing Therapeutics: How Base Editing, Prime Editing, and Next-Generation Delivery Systems Are Addressing the Safety and Tissue-Specific Targeting Challenges Limiting Clinical Translation-1
シェア
金金の他の作品
foriio

あなたのforiioを無料で作成

fori.io/
CRISPR-Cas Gene Editing Therapeutics: How Base Editing, Prime Editing, and Next-Generation Delivery Systems Are Addressing the Safety and Tissue-Specific Targeting Challenges Limiting Clinical Translation-1
金金の他の作品
foriio

あなたのforiioを無料で作成

fori.io/